Incidental association of thyroid carcinoma and squamous cell carcinoma of head and neck

被引:15
|
作者
Coskun, H
Erisen, L
Tolunay, S
Basut, O
Onart, S
Tezel, I
机构
[1] Uludag Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, TR-16059 Bursa, Turkey
[2] Uludag Univ, Sch Med, Dept Pathol, TR-16059 Bursa, Turkey
关键词
D O I
10.1053/ajot.2002.124541
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose: This study was carried out to address the dilemma of managing incidentally associated squamous cell carcinoma of the head and neck and thyroid carcinoma. Materials and Methods: The patient group consists of 229 consecutive cases of squamous cell carcinoma of the head and neck and who were treated surgically at the Uludag University School of Medicine Department of Otolaryngology over a four-year period between 1997 and 2000. Results: Among these patients, 3 had additional thyroid papillary carcinoma metastases (1.3%, 3/229) within the surgical specimens of the surgical procedures performed for squamous cell carcinoma of the head and neck. Complementary thyroidectomy was recommended but could not be performed in one of three cases because of the patient's refusal, and the primary focus of thyroid carcinoma could be found in only one of these two cases who had undergone complementary thyroidectomy. All three patients received postoperative radioactive iodine and thyroid hormone suppression, and all are free of disease after 49, 46, and 19 months of follow-up, respectively. Conclusions: Management of thyroid carcinoma found incidentally during treatment of squamous cell carcinoma of the head and neck is still debatable, and all patients must be evaluated individually with regard to its benefit. Our limited experience suggests that total thyroidectomy may not be regarded as mandatory in managing these patients. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:228 / 232
页数:5
相关论文
共 50 条
  • [31] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Jessica Moskovitz
    Jennifer Moy
    Robert L. Ferris
    [J]. Current Oncology Reports, 2018, 20
  • [32] Recurrent head and neck squamous cell carcinoma
    Wu, S-Y.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [33] Basaloid squamous cell carcinoma of the head and neck
    Paulino, AFG
    Singh, B
    Shah, JP
    Huvos, AG
    [J]. LARYNGOSCOPE, 2000, 110 (09): : 1479 - 1482
  • [34] Squamous cell carcinoma of the head and neck in children
    Dombrowski, Natasha D.
    Wolter, Nikolaus E.
    Irace, Alexandria L.
    Robson, Caroline D.
    Perez-Atayde, Antonio R.
    Mack, Jennifer W.
    Rahbar, Reza
    [J]. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2019, 117 : 131 - 137
  • [35] Pharmacotherapy of head and neck squamous cell carcinoma
    Pan, Quintin
    Gorin, Michael A.
    Teknos, Theodoros N.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (14) : 2291 - 2302
  • [36] Chemoprevention of squamous cell carcinoma of the head and neck
    Wrangle, John M.
    Khuri, Fadlo R.
    [J]. CURRENT OPINION IN ONCOLOGY, 2007, 19 (03) : 180 - 187
  • [37] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Schoppy, David W.
    Sunwoo, John B.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) : 1033 - +
  • [38] Nivolumab in squamous cell carcinoma of the head and neck
    Specenier, Pol
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 409 - 420
  • [39] Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
    Wang, Lei
    Pang, Wenjing
    Zhou, Kun
    Li, Lei
    Wang, Feng
    Cao, Wei
    Meng, Xiangjun
    [J]. JOURNAL OF ONCOLOGY, 2022, 2022
  • [40] Human Papillomavirus Genotype Association With Survival in Head and Neck Squamous Cell Carcinoma
    Bratman, Scott V.
    Bruce, Jeffrey P.
    O'Sullivan, Brian
    Pugh, Trevor J.
    Xu, Wei
    Yip, Kenneth W.
    Liu, Fei-Fei
    [J]. JAMA ONCOLOGY, 2016, 2 (06) : 823 - 826